Explainer: What is proton therapy?

August 1, 2013 by Suzy Sheehy, The Conversation
A bit too big for your average hospital. Credit: Ars Electronica

When you stand in the 27km-long Large Hadron Collider tunnel deep under Switzerland and France it looks as if the chain of blue magnets simply stretches off to infinity. So when people talk about putting particle accelerators in hospital basements to treat cancer, there is understandably some reticence as to their size and cost.

Despite this, is big business. According to the Particle Therapy Co-Operative Group, by 2012 more than 100,000 patients had been treated with charged particles worldwide. Of those, roughly 94,000 were treated with protons, which are positively charged .

Firing protons at the body

In 1944, the physicist R R Wilson published a paper titled "Radiological use of fast protons" in a medical journal. The paper described how new high-energy particle accelerators could provide protons or other that would penetrate deep enough into the body to do something useful; say, kill a .

When treating any cancer with radiation the aim is to increase the dose reaching while sparing as much of the healthy tissue as possible. For tumours deep inside the body or in the brain this can become particularly difficult. Such selectivity is also crucial in many cases of cancer in young children who are still developing.

Protons are good candidates for such selectivity because they deposit low- when travelling through the body, but a heavy dose when they are eventually stopped. The place where the stop inside the body can be determined by knowing the energy at which they were fired from the . This allows fine control over where most of the is delivered.

In typical X-ray radiotherapy, the dose of radiation is actually greatest just under the skin and then drops off with depth. In proton therapy, doctors can choose where the dosage is heaviest. If you want a higher dose inside the body, use a heavier ion, such as helium or carbon, which will be able to deposit more energy inside the body, rather than on the surface.

Proof is in the proton

Surprisingly, there are no proper randomised clinical trials that "prove" proton therapy is superior to X-ray radiotherapy. In fact, ethical considerations may rule them out. If we already know from the physics that proton therapy is superior, then it could be considered unethical to offer patients conventional radiotherapy who are being used as control.

Previous developments in conventional radiotherapy, such as the move from analogue X-rays to digital, or from hand-calculated treatment plans to simulation codes were simply approved and adopted immediately. Many centres offering this treatment consider it as just another type of radiation to be used in radiotherapy, not an entirely new treatment.

In practice it turns out to be a little more challenging than the basic physics leads us to believe. This is one reason why the Particle Therapy Cancer Research Institute in Oxford was created, which brings together physicists, IT experts, biologists and oncologists to try and address some key questions in the field.

Physicists fighting cancer

Every cancer is different. So for any given cancer, we need to be able to determine the most effective combination of therapies which are needed to achieve a cure including surgery, conventional radiotherapy, chemotherapy, gene therapies and methods like proton or ion therapy.

With the current trend toward using heavier ions, such as carbon, more research is needed to understand whether they provide a real clinical benefit and also to ascertain which ion is the best compromise once all the complexities are taken into account.

In the meantime, physicists are contributing to proton and ion therapy through the development of new accelerators and new imaging technologies to help oncologists deliver the best treatment possible.

Explore further: Despite hype, costly prostate cancer treatment offers little relief from side effects

Related Stories

Despite hype, costly prostate cancer treatment offers little relief from side effects

December 13, 2012
Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a standard radiation ...

Japan hospital tests powerful breast cancer therapy

May 22, 2013
A Japanese cancer specialist said Wednesday she has started the world's first clinical trial of a powerful, non-surgical, short-term radiation therapy for breast cancer.

Scientists examine proton radiography of brain mockup

March 26, 2013
Los Alamos researchers and German collaborators have investigated the application of giga-electron volt (GeV, or billion electron volts) energy proton beams for medical imaging in combination with proton radiation treatment ...

Study investigates proton radiation effects on cells

August 5, 2012
(Phys.org) -- A team of researchers at NASA's Johnson Space Center in Houston and Lawrence Berkeley National Laboratory in Berkeley, Calif., has found radiation from protons could further enhance a process that occurs during ...

Recommended for you

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.